Last updated on: 05/04/2022
Name of organisation
1) Department/Research groupPharmacologie En Population cohorteS biobanqueS
2) Organisation/affiliationHopitaux de Toulouse
Short Name in the inventoryPEPSS
Administrative Contact
Title Dr
Last name Lapeyre-Mestre
First name Maryse
Address line 137 Allees Jules Guesde
Address line 2
Address line 3
CityToulouse
Postcode31000
CountryFrance
Phone number (incl. country code)33-561145960
Alternative phone number33-561145606
Fax number (incl. country code)33-561145928
Scientific Contact
Title Dr
Last name Lapeyre-Mestre
First name Maryse
Address line 137 Allees Jules
Address line 2
Address line 3
CityToulouse
Postcode31000
CountryFrance
Phone number (incl. country code)33-561145960
Alternative phone number33-561145606
Fax number (incl. country code)33-561145928
2. Description
The research team of pharmacoepidemiology is one of the 6 research teams of the INSERM Unit “Epidemiology and Public Health Analysis: Risks, chronic illnesses and disabilities". This team consists of academic researchers involved in the field of clinical pharmacology, internal medicine and general medicine. The research activity focuses on analysing drug-related risk from different data sources (spontaneous reporting system, health insurance and hospital medical data). The main topics concern drug exposure in pregnancy, drug abuse and pharmacovigilance
3. Category
University based
Hospital based
4. Available resources
In houseVia Contacts/Network
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Congenital Malformations
Disorders of the central nervous system
Geriatrics
Immunological products and vaccines
Immunosuppression
Infectious diseases
Malignant disease
Musculoskeletal and joint diseases
Neonates
Psychiatry
addiction
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
Health insurance system
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
CPRD2
French PV database10
Hospital Discharge5
SNDS - Système National des Données de Santé10
Echantillon Généraliste des Bénéficiaires (EGB) France4
11. Registries established by centre
Other CARMEN registry (National registry of patients with autoimmune cytopenias
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
None
14. Interest in research opportunities which are funded
By charities
By government
15. Interest in contract research only if free to publish results
Yes
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network. Moulis G, Cooper N, Ghanima W, González-López T, Kühne T, Lozano ML, Michel M, Provan D, Zaja F, Aladjidi N, Christiansen CF, Frederiksen H, Grainger J, McDonald V, Robinson S, Schifferli A, Rodeghiero F. Br J Haematol. 2022 Mar 18. doi: 10.1111/bjh.18111. https://onlinelibrary.wiley.com/doi/10.1111/bjh.18111
Use of the French national health insurance information system for research in the field of mental health: Systematic review and perspectives.
Revet A, Moulis G, Raynaud JP, Bui E, Lapeyre-Mestre M. Fundam Clin Pharmacol. 2022 Feb;36(1):16-34. doi: 10.1111/fcp.12696. https://onlinelibrary.wiley.com/doi/10.1111/fcp.12696
Evaluation of Prescription Practices of Domperidone in Parkinson's Disease: A Cross Sectional Study Among French Neurologists.
Lastennet D, Mariani LL, Rascol O, Turc JD, Alfaisal H, Lapeyre-Mestre M, Corvol JC, Tubach F. CNS Drugs. 2020 Dec;34(12):1267-1274. doi: 10.1007/s40263-020-00774-w. https://link.springer.com/article/10.1007/s40263-020-00774-w
